Table of Contents Author Guidelines Submit a Manuscript
Neuroscience Journal
Volume 2013, Article ID 424695, 9 pages
http://dx.doi.org/10.1155/2013/424695
Clinical Study

Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol

1Clinic of Neurology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland
2Department of Radiology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland
3Clinic of Ophthalmology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland
4Department of Laboratory Medicine, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland

Received 16 September 2012; Accepted 11 December 2012

Academic Editor: Atul Goel

Copyright © 2013 Jacek Staszewski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. D. Prins, E. J. Van Dijk, T. Den Heijer et al., “Cerebral white matter lesions and the risk of dementia,” Archives of Neurology, vol. 61, no. 10, pp. 1531–1534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Baezner, C. Blahak, A. Poggesi et al., “Association of gait and balance disorders with age-related white matter changes: the LADIS Study,” Neurology, vol. 70, no. 12, pp. 935–942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Pantoni, “Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges,” The Lancet Neurology, vol. 9, no. 7, pp. 689–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. C. Vogels, W. M. Flier, HartenB et al., “Brain magnetic resonance imaging abnormalities inpatients with heart failure,” European Journal of Heart Failure, vol. 9, pp. 1003–1009, 2007. View at Publisher · View at Google Scholar
  5. R. P. W. Rouhl, J. G. M. Damoiseaux C, J. Lodder et al., “Vascular inflammation in cerebral small vessel disease,” Neurobiology of Aging, vol. 33, no. 8, pp. 1800–1806. View at Publisher · View at Google Scholar
  6. L. Pantoni and J. H. Garcia, “Pathogenesis of leukoaraiosis: a review,” Stroke, vol. 28, no. 3, pp. 652–659, 1997. View at Google Scholar · View at Scopus
  7. J. M. Wardlaw, “What causes lacunar stroke?” Journal of Neurology, Neurosurgery & Psychiatry, vol. 76, pp. 617–619, 2005. View at Publisher · View at Google Scholar
  8. J. C. Zijlmans, S. E. Daniel, A. J. Hughes, T. Revesz, and A. J. Lees, “Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis,” Movement Disorders, vol. 19, pp. 630–640.
  9. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria For Research, World Health Organization, Geneva, Switzerland, 1993.
  10. A. Hassan, B. J. Hunt, M. O'Sullivan et al., “Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis,” Brain, vol. 126, no. 2, pp. 424–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. K. Yip, C. W. Liou, H. W. Chang, M. Y. Lan, J. S. Liu, and M. C. Chen, “Link between platelet activity and outcomes after an ischemic stroke,” Cerebrovascular Diseases, vol. 20, no. 2, pp. 120–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Iemolo, G. Duro, C. Rizzo, L. Castiglia, V. Hachinski, and C. Caruso, “Pathophysiology of vascular dementia,” Immun Ageing, vol. 6, article 13, 2009. View at Publisher · View at Google Scholar
  13. S. L. M. Bakker, F. E. De Leeuw, J. C. De Groot, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler, “Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly,” Neurology, vol. 52, no. 3, pp. 578–583, 1999. View at Google Scholar · View at Scopus
  14. A. Y. Gur, D. Gücüyener, N. Üzüner et al., “Cerebral vasomotor reactivity of patients with acute ischemic stroke: cortical versus subcortical infarcts: an Israeli-Turkish collaborative study,” Journal of the Neurological Sciences, vol. 257, no. 1-2, pp. 121–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ruitenberg, T. Den Heijer, S. L. M. Bakker et al., “Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study,” Annals of Neurology, vol. 57, no. 6, pp. 789–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Hatazawa, E. Shimosegawa, T. Satoh, H. Toyoshima, and T. Okudera, “Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging,” Stroke, vol. 28, no. 10, pp. 1944–1947, 1997. View at Google Scholar · View at Scopus
  17. J. Bamford, P. Sandercock, L. Jones, and C. Warlow, “The natural history of lacunar infarction: the Oxfordshire Community Stroke Project,” Stroke, vol. 18, no. 3, pp. 545–551, 1987. View at Google Scholar · View at Scopus
  18. H. P. Adams, “Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial,” Journal of the American Medical Association, vol. 279, no. 16, pp. 1265–1272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. H. I. Hurtig, “Vascular Parkinsonism,” in Parkinsonian Syndromes, M. B. Stem and W. C. Koller, Eds., pp. 81–93, Marcel-Dekker, New York, NY, USA.
  20. H. C. Chui, J. I. Victoroff, D. Margolin, W. Jagust, R. Shankle, and R. Katzman, “Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers,” Neurology, vol. 42, no. 3 I, pp. 473–480, 1992. View at Google Scholar · View at Scopus
  21. G. C. Roman, T. K. Tatemichi, T. Erkinjuntti et al., “Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop,” Neurology, vol. 43, no. 2, pp. 250–260, 1993. View at Google Scholar · View at Scopus
  22. S. Wiederkehr, M. Simard, C. Fortin, and R. Van Reekum, “Validity of the clinical diagnostic criteria for vascular dementia: a critical review. Part II,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 20, no. 2, pp. 162–177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. E. G. Grant, C. B. Benson, G. L. Moneta et al., “Carotid artery stenosis: gray-scale and doppler US diagnosis—society of radiologists in ultrasound consensus conference,” Radiology, vol. 229, no. 2, pp. 340–346, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Sloan, A. V. Alexandrov, C. H. Tegeler et al., “Assessment: transcranial doppler ultrasonography. report of the therapeutics and technology assessment subcommittee of the american academy of neurology,” Neurology, vol. 62, no. 9, pp. 1468–1481, 2004. View at Google Scholar · View at Scopus
  25. J. A. Whitworth, “2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension,” Journal of Hypertension, vol. 21, no. 11, pp. 1983–1992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Handelsman, J. I. Mechanick, L. Blonde et al., “American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary,” Endocrine Practice, vol. 17, supplement 2, pp. 287–302, 2011. View at Google Scholar · View at Scopus
  27. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  28. L. B. Goldstein, C. Bertels, and J. Davis, “Interrater reliability of the NIH stroke scale,” Archives of Neurology, vol. 46, no. 6, pp. 660–662, 1989. View at Google Scholar · View at Scopus
  29. K. Berg, S. Wood-Dauphinee, J. I. Williams, and D. Gayton, “Measuring balance in the elderly: preliminary development of an instrument,” Physiotherapy Canada, vol. 41, no. 6, pp. 304–311, 1989. View at Google Scholar · View at Scopus
  30. M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini mental state”. a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Wechsler, Wechsler Memory Scale-Revised Manual, Psychological Corporation, San Antonio, Tx, USA, 1987.
  32. S. A. Benton, Benton Visual Retention Test, The Psychological Corporation, San Antonio, Tx, USA, 5th edition, 1992.
  33. E. A. Bergh, “A simple objective technique for measuring flexibility in thinking,” The Journal of General Psychology, vol. 39, pp. 15–22, 1948. View at Google Scholar
  34. K. L. Bryan, “Language prosody and the right hemisphere,” Aphasiology, vol. 3, no. 4, pp. 285–299, 1989. View at Google Scholar · View at Scopus
  35. O. Spreen and A. H. Risser, Assessment of Aphasia, Oxford University Press, Oxford, UK, 2003.
  36. O. Spreen and A. L. Benton, Neurosensory Center Comprehensive Examination for Aphasia. Manual and Instructions, University of Victoria, Victoria, Canada, 1969.
  37. B. Agrell and O. Dehlin, “The clock-drawing test,” Age and Ageing, vol. 27, no. 3, pp. 399–403, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Yesavage, T. L. Brink, and T. L. Rose, “Development and validation of a geriatric depression screening scale: a preliminary report,” Journal of Psychiatric Research, vol. 17, no. 1, pp. 37–49, 1982. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Morris, “The Clinical Dementia Rating (CDR): current version and scoring rules,” Neurology, vol. 43, no. 11, pp. 2412–2414, 1993. View at Google Scholar · View at Scopus
  40. C. A. McHorney, J. E. Ware, and A. E. Raczek, “The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs,” Medical Care, vol. 31, no. 3, pp. 247–263, 1993. View at Google Scholar · View at Scopus
  41. W. G. Bradley, “Hemorrhage and brain iron,” in Magnetic Resonance Imaginged, Mosby, St Louis, Mo, USA, 2nd edition, 1992. View at Google Scholar
  42. M. W. Vernooij, M. A. Ikram, H. L. Tanghe et al., “Incidental findings on brain MRI in the general population,” New England Journal of Medicine, vol. 357, no. 18, pp. 1821–1828, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. L. O. Wahlund, F. Barkhof, F. Fazekas et al., “A new rating scale for age-related white matter changes applicable to MRI and CT,” Stroke, vol. 32, no. 6, pp. 1318–1322, 2001. View at Google Scholar · View at Scopus
  44. F. Fazekas, J. B. Chawluk, and A. Alavi, “MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging,” American Journal of Roentgenology, vol. 149, no. 2, pp. 351–356, 1987. View at Google Scholar · View at Scopus
  45. P. M. Parizel, L. van den Hauwe, F. de Belder et al., “Magnetic resonance imaging of the brain,” in Clinical MR Imaging. A Practical Approach, P. Reimer, P. M. Parizel, J. F. M. Meaney, and F. A. Stichnoth, Eds., pp. 187–189, Springer, 2010. View at Google Scholar
  46. F. Pasquer, D. Leys, J. G. E. Weerts, F. Mounier, FrederikBarkhof, and P. Scheltens, “Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts,” European Neurology, vol. 36, no. 5, pp. 268–272, 1996. View at Google Scholar · View at Scopus
  47. C. P. Derdeyn, R. L. Grubb, and W. J. Powers, “Cerebral hemodynamic impairment: methods of measurement and association with stroke risk,” Neurology, vol. 53, no. 2, pp. 251–259, 1999. View at Google Scholar · View at Scopus
  48. A. D. Wijnhoud, M. Franckena, A. van der Lugt, P. J. Koudstaal, and E. D. W. J. Dippel, “Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density,” Ultrasound in Medicine and Biology, vol. 34, no. 6, pp. 923–929, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Settakis, C. Molnár, L. Kerényi et al., “Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature,” European Journal of Neurology, vol. 10, no. 6, pp. 609–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Provinciali, M. G. Ceravolo, and P. Minciotti, “A transcranial Doppler study of vasomotor reactivity in symptomatic carotid occlusion,” Cerebrovascular Diseases, vol. 3, pp. 27–32, 1993. View at Publisher · View at Google Scholar
  51. G. Settakis, A. Lengyel, C. Molnár, D. Bereczki, L. Csiba, and B. Fülesdi, “Transcranial Doppler study of the cerebral hemodynamic changes during breath-holding and hyperventilation tests,” Journal of Neuroimaging, vol. 12, no. 3, pp. 252–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. H. S. Markus and M. J. G. Harrison, “Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus,” Stroke, vol. 23, no. 5, pp. 668–673, 1992. View at Google Scholar · View at Scopus
  53. G. Kozera and W. Nyka, “Zastosowanie przezczaszkowej ultrasonografii dopplerowskiej w ocenie autoregulacji przepływu mózgowego,” in Podrecznik Diagnostyki Ultrasonograficznej w Neurologii, R. Kazmierski, Ed., pp. 325–339, Wydawnictwo Czelej, 2011. View at Google Scholar
  54. J. M. De Bray and B. Glatt, “Quantification of atheromatous stenosis in the extracranial internal carotid artery,” Cerebrovascular Diseases, vol. 5, pp. 141–126, 1995. View at Publisher · View at Google Scholar
  55. M. C. Corretti, T. J. Anderson, E. J. Benjamin et al., “Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force,” Journal of the American College of Cardiology, vol. 39, no. 2, pp. 257–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. M. L. Bots, J. Westerink, T. J. Rabelink, and E. J. P. De Koning, “Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response,” European Heart Journal, vol. 26, no. 4, pp. 363–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. O. Tóth, A. Calatzis, S. Penz, H. Losonczy, and W. Siess, “Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood,” Thrombosis and Haemostasis, vol. 96, no. 6, pp. 781–788, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. L. D. Hubbard, R. J. Brothers, W. N. King et al., “Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study,” Ophthalmology, vol. 106, no. 12, pp. 2269–2280, 1999. View at Google Scholar · View at Scopus
  59. R. Schmidt, F. Fazekas, P. Kapeller, H. Schmidt, and H. P. Hartung, “MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study,” Neurology, vol. 53, no. 1, pp. 132–139, 1999. View at Google Scholar · View at Scopus
  60. E. J. Van Dijk, N. D. Prins, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler, “Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study,” Stroke, vol. 39, no. 10, pp. 2712–2719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. E. M. Macy, T. E. Hayes, and R. P. Tracy, “Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications,” Clinical Chemistry, vol. 43, no. 1, pp. 52–58, 1997. View at Google Scholar · View at Scopus
  62. H. S. Markus, B. Hunt, K. Palmer, C. Enzinger, H. Schmidt, and R. Schmidt, “Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study,” Stroke, vol. 36, no. 7, pp. 1410–1414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. M. O. Giwa, J. Williams, K. Elderfield et al., “Neuropathologic evidence of endothelial changes in cerebral small vessel disease,” Neurology, vol. 78, no. 3, pp. 167–174, 2012. View at Google Scholar
  64. A. G. W. van Norden, K. F. de Laat, R. A. R. Gons et al., “Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol,” BMC Neurology, vol. 11, article no. 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Behrouz, A. R. Malek, and M. T. Torbey, “Small vessel cerebrovascular disease: the past, present, and future,” Stroke Research and Treatment, vol. 2012, Article ID 839151, 8 pages, 2012. View at Publisher · View at Google Scholar